According to a joint analysis by the World Health Organization (WHO) and the European Centre for Disease Prevention and Control, a dangerous trend is observed in the region: common antibiotics are losing effectiveness against several infectious agents. This directly increases the likelihood of severe complications and fatal outcomes in patients.
Threat from Klebsiella and Acinetobacter
The primary danger is posed by two bacteria: Klebsiella pneumoniae and Acinetobacter. They are frequent causes of serious hospital-acquired infections, including bloodstream infections. The situation is complicated by the fact that these bacteria are developing resistance to drugs that doctors typically use as a first line of defense.
In several countries, studied bacterial samples demonstrate ineffectiveness even against the strongest classes of drugs. This forces medical professionals to use reserve antibiotics, which are often significantly more expensive and not always available in healthcare facilities.
Bacterial resistance indicators
Context
The World Health Organization is an international organization headquartered in Geneva, founded in 1948. The issue affects the Central Asian region, where more than 80 million people reside.







